Calamos Advisors LLC Axogen, Inc. Transaction History
Calamos Advisors LLC
- $15.7 Billion
- Q1 2025
A detailed history of Calamos Advisors LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Calamos Advisors LLC holds 40,789 shares of AXGN stock, worth $659,966. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,789
Previous 31,725
28.57%
Holding current value
$659,966
Previous $522,000
44.44%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AXGN
# of Institutions
181Shares Held
36.6MCall Options Held
82.6KPut Options Held
1.1K-
First Light Asset Management, LLC Edina, MN4.51MShares$72.9 Million7.26% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$52.6 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.96MShares$47.8 Million3.39% of portfolio
-
Morgan Stanley New York, NY2.43MShares$39.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$39.3 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $684M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...